Nectero EAST System Clinical Study
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.
Also called NCT06001918
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 400 participants
- Sponsor
- Nectero Medical, Inc.
- Registry
-
NCT06001918
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, New Zealand
- Registry status
- Recruiting
Technical summary
Registry record NCT06001918. Randomized; single masking; primary purpose treatment. Start 2023-10-25 (actual); primary completion 2028-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Nectero EAST System Clinical Study
- Acronym
- stAAAble
- Condition
- Abdominal Aortic Aneurysm
- Intervention (Drug)
- Nectero EAST System
- Lead sponsor
- Nectero Medical, Inc.
Record details
- Record id
cardio:ct-nct06001918- Content hash
6ce63a2b8751a0d35a24235cf275b7346607dc46c004a28f079c7b5ff09d5945